DIN 02454416 — DESCOVY 10 MG; 200 MG
DESCOVY is a tablet of Emtricitabine / Tenofovir Alafenamide marketed by GILEAD SCIENCES CANADA INC. The full Emtricitabine / Tenofovir Alafenamide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02454416
- Brand name
- DESCOVY
- Active ingredient
- Emtricitabine / Tenofovir Alafenamide
- Strength
- 10 MG; 200 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- GILEAD SCIENCES CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Nucleos(t)ide Reverse Transcriptase Inhibitor (NRTI) Combination - Antiretroviral Agent
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Emtricitabine / Tenofovir Alafenamide products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02454424 | DESCOVY | 25 MG; 200 MG | TABLET | GILEAD SCIENCES CANADA INC | MARKETED |